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ABSTRACT
Background: Weight loss has been shown to reduce risk factors
associated with cardiovascular disease and diabetes; however, suc-
cessful maintenance of weight loss continues to pose a challenge.
Objective: The present study was designed to assess whether
changes in subcutaneous adipose tissue (scAT) gene expression
during a low-calorie diet (LCD) could be used to differentiate and
predict subjects who experience successful short-term weight main-
tenance from subjects who experience weight regain.
Design: Forty white women followed a dietary protocol consisting
of an 8-wk LCD phase followed by a 6-mo weight-maintenance
phase. Participants were classified as weight maintainers (WMs;
0–10% weight regain) and weight regainers (WRs; 50–100% weight
regain) by considering changes in body weight during the 2 phases.
Anthropometric measurements, bioclinical variables, and scAT gene
expression were studied in all individuals before and after the LCD.
Energy intake was estimated by using 3-d dietary records.
Results: No differences in body weight and fasting insulin were
observed between WMs and WRs at baseline or after the LCD
period. The LCD resulted in significant decreases in body weight
and in several plasma variables in both groups. WMs experienced
a significant reduction in insulin secretion in response to an oral-
glucose-tolerance test after the LCD; in contrast, no changes in
insulin secretion were observed in WRs after the LCD. An ANOVA
of scAT gene expression showed that genes regulating fatty acid
metabolism, citric acid cycle, oxidative phosphorylation, and apopto-
sis were regulated differently by the LCD in WM and WR subjects.
Conclusion: This study suggests that LCD-induced changes in in-
sulin secretion and scAT gene expression may have the potential to
predict successful short-term weight maintenance. This trial was
registered at clinicaltrials.gov as NCT00390637. Am J Clin
Nutr 2011;94:1399–409.
INTRODUCTION
Obesity is associated with an increased risk of cardiovascular
disease, diabetes, metabolic syndrome, and a number of cancers;
however, weight loss of 5–10% has repeatedly been shown to
convey modest to significant reductions in the risk of these
downstream complications (1). The most common strategy to
promote weight loss in obesity involves modifying lifestyle via
changes in dietary and exercise habits. Although reduced caloric
intake and increased physical activity favor a reduction in body
weight body fat mass and improvements in metabolic parameters,
one of the greatest difficulties for obesity management is weight
maintenance after successful weight loss.
Several meta-analyses have shown that energy restriction,
increased physical activity, or both can lead to successful short-
term weight loss; however, the long-term effectiveness of these
interventions appears challenging (2, 3). Numerous factors have
been shown to influence successful weight maintenance, in-
cluding behavior (4), physical activity (2), eating habits (5), the
length of time an individual has maintained weight loss (6), the
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degree of energy deficit and consequent weight loss (3, 7), and
the influence of altering dietary macronutrient content (ie, car-
bohydrate, protein, and fat) (8–11). It is now widely accepted that
body weight and body composition are also influenced by a ge-
netic component (which encompasses genetic polymorphisms,
epigenetics, and gene transcription); however, our understanding
of how these genetic determinants contribute to successful weight
maintenance remains limited (12).
Diet-induced weight loss in overweight and obese individuals
decreases the expression of genes associated with PUFA me-
tabolism, inflammation, and cell death and modifies the ex-
pression of genes encoding components of the extracellular
matrix (13–17). Previous attempts to predict an individual’s
response (ie, high compared with low weight loss) using only
scAT4 gene expression profiles appear to be limited, suggesting
that alternate approaches may be required to improve prediction
accuracy (18, 19).
Studying changes in gene expression has provided novel in-
sight to help clarify the molecular basis for the metabolic
improvements associated with diet-induced weight loss. For
example, Capel et al (20) highlighted the interplay between im-
mune cells and adipocytes during the various phases of a weight-
loss program (caloric restriction and weight stabilization) by
monitoring scAT gene expression profiles. Recently, Ma´rquez-
Quin˜ones et al (11) focused on the weight-maintenance phase of
the DiOGenes study and found that unsuccessful participants (ie,
subjects who regained weight after an LCD phase) had an in-
creased expression of genes related to cellular growth and dif-
ferentiation (11).
The present study was designed to further contribute to our
understanding of the interindividual variability regarding suc-
cessful weight maintenance by determining whether scAT gene
expression profiles during an LCD can be used to differentiate
and predict subjects who experience successful short-termweight
maintenance from participants who experience weight regain.
This study provides important knowledge that may prove ben-
eficial in the long term for the development of personalized
strategies to improve successful weight maintenance.
SUBJECTS AND METHODS
Dietary intervention study
This study is part of the European Framework project entitled
Diet, Obesity, and Genes (DiOGenes). For a thorough description
of the overall objective and goals of this dietary intervention, see
Larsen et al (21) and Moore et al (22). Briefly, the project
consisted of 2 phases: an initial weight-loss phase and a 6-mo
weight-maintenance phase. A total of 932 overweight and obese
white adults were recruited from across 8 European countries to
study the effects of dietary macronutrients on weight regain and
cardiovascular risk factors. Inclusion and exclusion criteria for
study participation were outlined previously (21). Of relevance
to the current study, all subjects were weight stable (,3 kg
change in body weight) during the 2-mo period before initiating
the study. The initial weight-loss phase consisted of an 8-wk
LCD (3300 kJ/d, ~800 kcal; Modifast; Nutrition et Sante´). Only
those participants who achieved the targeted weight loss (8%
of initial body weight) were invited to continue the protocol.
Subjects were randomly assigned to the weight-maintenance
phase as described (21). During this weight-maintenance phase,
participants consumed ad libitum 1 of 4 low-fat (20–25% of
energy intake) diets that differed in GI and protein content (23).
More specifically, subjects adhered to one of the following diets:
LGI/LP, HGI/LP, LGI/HP, or HGI/HP. Target energy intakes in
the LP diets were 10–15% protein and 57–62% carbohydrates
and in the HP diets were 23–28% protein and 45–50% carbo-
hydrates. The goal was to achieve a difference of ~15 GI points
between the LGI and HGI diets. During this weight-maintenance
period, subjects met with a dietitian at regular intervals.
The study was approved by local ethics committees in the
various countries. The protocol was in accordance with the
Declaration of Helsinki. All study participants provided written
consent.
Blood sampling
Fasting blood samples were obtained at each of the 3 CIDs for
the analysis of blood metabolites, as outlined in Larsen et al (21).
An OGTT lasting 120 min was also performed at each CID after
the consumption of 75 g glucose.
Subject selection
Of the 548 subjects that completed the entire dietary protocol,
a subset of 227 women were selected according to the following
criteria: age between 20–50 y, nondiabetic (fasting glucose 7
mmol/L), nondyslipidemic (fasting cholesterol 7 mmol/L and
fasting triglycerides 3.6 mmol/L), availability of a fat biopsy
at the required time points, and a complete clinical evaluation
during the protocol (see Supplementary Figure 1 under “Sup-
plemental data” in the online issue). Body weight and energy
intake measurements at the 3 time points were necessary: CID 1
(before commencing the LCD), CID 2 (at the end of the LCD
phase), and CID 3 (at the end of the 6-mo weight-maintenance
phase) (21).
Previously, Ma´rquez-Quin˜ones et al (11) reported negligible
differences in scAT expression profiles between participants in
the various weight-maintenance diets; therefore, subjects in the 4
different dietary branches were considered all together. Subjects
were classified according to changes in body weight during the
weight-maintenance period, which was expressed as a percentage
of weight lost during the LCD period. Subjects who experienced
0–10% and 50–100%weight regain during theweight-maintenance
period were classified as weight maintainers (WMs) and weight
regainers (WRs), respectively. Of the 227 women available, a
subset of 20 subjects were randomly selected for each group
and matched for the following bioclinical variables at both CID
1 and CID 2 time points: body weight (kg), BMI (in kg/m2),
total energy intake (kJ/d), and fasting cholesterol (mmol/L),
triglycerides (mmol/L), HDL cholesterol (mmol/L), fructosamine
lmol/L), adiponectin (lg/mL), C-reactive protein (mg/L), glucose
(mmol/L), insulin (lIU/mL), and insulin resistance (HOMA-IR).
4Abbreviations used: CID, clinical investigation day; DiOGenes, Diet,
Obesity, and Genes; EHMN, Edinburgh human metabolic network; GI, gly-
cemic index; HGI, high glycemic index; HP, high protein; KEGG, Kyoto
Encyclopedia of Genes and Genomes; LCD, low-calorie diet; LGI, low
glycemic index; LP, low protein; OGTT, oral-glucose-tolerance test; RT-
PCR, reverse transcriptase polymerase chain reaction; scAT, subcutaneous
adipose tissue; WM, weight maintainer; WR, weight regainer.
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It is noteworthy to mention that WM and WR subjects were
not individually matched, but rather the WM and WR groups
as a whole were matched (ie, by using average values for
each variable).
Sample preparation and microarray analysis
scAT samples from the periumbilical area were obtained by
needle aspiration under local anesthesia after an overnight fast at
each of the time points. For the present prediction study only
biopsies at CID 1 and CID 2 were required. All procedures were
standardized between study centers across Europe, and biopsy
samples were stored at 280C until analysis. Total RNA was
extracted by using the RNeasy total RNA Mini kit (Qiagen).
Total RNA concentration and quality were confirmed by using
the Agilent 2100 Bioanalyzer (Agilent Technologies). Two
hundred nanograms of total RNA from each sample were am-
plified and transcribed into fluorescent complementary RNA by
using Agilent’s Low RNA Input Linear Amplification kit
(Agilent Technologies). Cyanine-5 dye was incorporated into all
scAT samples, whereas the reference pool was labeled with
cyanine-3 dye. The reference pool consisted of a commercial
mix of human liver, adipose tissue, heart, intestine, and skeletal
muscle RNA (AMBION/Applied Biosystems). A total of 80
samples (40 paired samples from CID 1 and CID 2) were ran-
domly hybridized to Agilent 4 · 44K whole human genome
microarrays, which are composed of .41,000 unique 60-mer
oligonucleotide human sequences and transcripts. Sample
preparation, hybridization, and microarray washing were per-
formed according to the manufacturer’s recommendations
(Agilent Technologies). Arrays were scanned by using a Gene-
Pix 4000A Scanner (Axon Instruments-Molecular Devices). The
complete data set is available in the NCBI Omnibus (http://
www.ncbi.nlm.nih.gov/geo/) through the series accession num-
ber GSE24432.
Real-time RT-PCR analysis
A subset of genes was validated by real-time RT–PCR in 17
WMs and 17 WRs (sufficient RNA was not available for all 40
subjects). Reverse transcription was performed with 0.5 mg total
RNA and random hexamer primers, according to the manu-
facturer’s instructions (Promega). RT-PCR amplification was
performed by using an ABI 7300 (Applied Biosystems) with the
following thermal cycling conditions: 2 min at 50C, 10 min at
95C, followed by 40 cycles at 95C for 15 s and at 60C for 1
min for denaturation, annealing, and elongation. All samples
were normalized to 18S gene expression (18S rRNA control kit;
Eurogentec). Differences in gene expression were assessed by
using a 2-tailed, homoscedastic Student’s t test. Specific primers
and probes were designed by using Universal ProbeLibrary
Assay Design Center by Roche Applied Science (https://www.
roche-applied-science.com).
Statistical analyses
Changes in bioclinical and anthropometric variables between
groups (WMs compared with WRs) and between times (CID 1
compared with CID 2) were analyzed by using JMP Genomics
version 4.1 software (SAS Institute). A mixed-model ANOVAwas
generated by using groups, times, and the interaction between
group and time (group · time) as fixed effects and the subject ID
as a random effect (to account for repeated measurements). Least-
square means were estimated for group · time conditions. A post
hoc Student’s t test was used to determine significance in specific
pairwise analyses. The AUC was calculated by using the trape-
zoid rule for both glucose and insulin response to the 120-min
OGTT. All data are presented as means 6 SEMs.
Microarray normalization was carried out by subtracting the
median intensity background signal before intraslide Loess
normalization of log-transformed data [Goulphar version 1.1.3
package (24)]. All data were then uploaded into the JMP
Genomics version 4.1 platform (SAS Institute) and further
normalized by using a quantile interslide intensity method.
Multiple probes corresponding to the same gene were averaged to
provide a single value for each GeneID per microarray. A mixed-
model ANOVA was generated by using groups (WMs, WRs),
times (CID 1, CID 2), and the interaction between group and time
(group · time) as fixed effects. Because each of the 40 in-
dividuals provided a biopsy at both time points, the model in-
cluded subjects as a random effect. Least-square means were
estimated for group-by-time conditions. A false discovery rate
of 0.01 was used to account for multiple testing.
FunNet analysis
The functional analysis of gene expression data was performed
by using FunNet (25). FunNet identifies KEGG biological
pathways that are overrepresented in gene expression data lists
while accounting for tests of multiplicity (false discovery rate =
0.05). Four lists of significant GeneIDs were obtained from the
ANOVA and used for the functional analyses: 1) weight main-
tainers, which corresponded to genes up- and downregulated by
the LCD that were identified in WM subjects only; 2) weight
regainers, which corresponded to genes up- and downregulated
by the LCD that were identified in WR subjects only; 3) di-
rectional concordance, which corresponded to genes up- and
downregulated by the LCD that were identified in both WM and
WR subjects; and 4) oppositely regulated, which corresponded
to genes that were regulated in both WM and WR subjects
during the LCD but in an opposite manner. More specifically,
upregulated pathways correspond to those genes that are
downregulated in WMs and upregulated in WRs, whereas
downregulated pathways correspond to those genes that are
upregulated in WMs and downregulated in WRs.
Reporter metabolite analysis
The global predictive analysis of enzyme-induced transcrip-
tional changes on metabolite concentrations was performed by
reporter metabolite analysis (26, 27) based on the EHMN re-
construction, which represents a high-confidence reconstructed
network of metabolism (28). The metabolic reconstruction forms
a bipartite network containing 2 kinds of nodes, enzymes and
metabolites. A metabolite is connected to an enzyme if it is
catalyzed (ie, produced or consumed) by that particular enzyme.
Therefore, metabolites will be linked only to enzymes and never
to each other, whereas enzymes will be linked only to metabolites
and never to each other. The reporter metabolite algorithm relies
on a rigorous statistical framework to identify metabolite nodes
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that are enriched in differentially expressed enzymatic genes
among their connected enzyme nodes. We compared our results
with those previously reported by Capel et al (20). Note that,
although the EHMN was used in both studies, the number of
enzymes detected in each network differed because the quality
control measures applied to the gene expression data were not
identical. The present analysis covered 1860 enzymes (80%
of the EHMN), 2166 metabolic reactions (76%), and 2225
metabolites in the EHMN. [See Supplementary Table 1 under
“Supplemental data” in the online issue for the EHMN coverage
for the Capel et al (20) analysis.] The reporter metabolite values
were generated by using Cytoscape 2.7.0 software (29).
RESULTS
Anthropometric and bioclinical data during the protocol
Subjects were classified into WM or WR groups according to
the percentage weight regain during the 6-mo weight-maintenance
phase, where WMs and WRs corresponded to participants who
regained 0–10% and 50–100% of the weight lost after the LCD,
respectively (Figure 1). Importantly, WM and WR groups were
established by ensuring that there was no difference at CID 1
(baseline) or CID 2 (after the LCD) for the anthropometric and
bioclinical variables listed in Table 1. All subjects lost a mini-
mum of 8% of their initial body weight during the LCD phase.
Energy restriction led to significant decreases in body weight,
BMI, cholesterol, triglycerides, HDL cholesterol, glucose, and
insulin in both WM and WR subjects (Table 1). Fructosamine,
adiponectin, C-reactive protein, and HOMA-IR were not sig-
nificantly changed by the LCD in a group-specific manner.
A group · time interaction analysis revealed that the re-
duction in circulating triglycerides observed after the LCD in
WM and WR subjects was borderline different (P = 0.0627). A
group-specific analysis found that triglyceride concentrations
were significantly reduced after the LCD in WMs (CID 1: 1.3 6
0.1 mmol/L; CID 2: 1.0 6 0.1 mmol/L; P = 0.0007) and not in
WRs (CID 1: 1.1 6 0.1 mmol/L; CID 2: 1.0 6 0.1 mmol/L; P =
0.3522). Although the differences in fasting insulin between
WM and WR groups were not statistically different at CID 1 and
CID 2, the group · time interaction analysis showed that there
was a difference in the reductions in fasting insulin after the
LCD between the 2 groups (P = 0.0479). Indeed, the reductions
in fasting insulin after the LCD appeared to be somewhat greater
in WM (CID 1: 10.9 6 1.1 lIU/mL; CID 2: 6.2 6 0.9 lIU/mL;
P , 0.0001) than in WR (CID 1: 8.9 6 0.8 lIU/mL; CID 2:
6.2 6 0.6 lIU/mL, P = 0.0004) subjects.
Energy intake during the protocol
Energy intake in all subjects was assessed at CID 1, 2 wk after
CID 2, and at CID 3 by using 3-d dietary records. Energy intake
during the LCD was fixed at 3300 kJ/d to ensure that energy
intake at CID 2 was equivalent for all study participants. Al-
though energy intake decreased significantly fromCID 1 to CID 2
in both groups, there was no difference in energy intake between
the groups at either CID 1 or CID 2 (data not shown). When
measuring mean energy intake at the end of the 6-mo weight-
maintenance phase (CID 3), no significant differences (P =
0.5770) were found between the WM (6226 6 533 kJ/d) and
WR (6788 6 875 kJ/d) groups. Nevertheless, and although not
significant, WM subjects consumed, on average, ~500 kJ/d less
than did WR subjects.
Changes in insulin secretion associated with 6-mo weight
maintenance
The AUC for glucose and insulin response after an OGTTwas
calculated in all subjects before and after the LCD. No significant
differences in glycemic response were detected between WMs
and WRs at either CID 1 or CID 2 (data not shown). In contrast,
the OGTT-induced insulin secretion was markedly higher in the
WM group than in the WR group at CID 1 (WM insulin AUC:
8245 6 881 lIU  min  mL21; WR insulin AUC: 5674 6 509
lIU  min  mL21; P , 0.0001), despite similar baseline fasting
insulin concentrations. A group · time interaction analysis in-
dicated that changes in insulin secretion after the LCD differed
between the 2 groups (P = 0.0123). More specifically, the LCD
resulted in a significant decrease in insulin secretion in the WM
group only. At CID 2 there was no significant difference in in-
sulin secretion between the 2 groups (WM insulin AUC: 51896
414; WR insulin AUC: 5235 6 482; P , 0.9888). This was
further reflected by changes in the individual data (see Supple-
mentary Figure 2 under “Supplemental data” in the online is-
sue). When plotting changes (ie, CID 2 – CID 1) in insulin
secretion at each time point during the OGTT for each of the 40
subjects, it was apparent that considerable variability exists
between individuals with regards to LCD-induced changes in
insulin response. Despite this interindividual variability, the WM
group experienced a significant decrease in insulin secretion
(P , 0.05) at each time point during the OGTT (30, 60, 90, and
120 min) at CID 2 compared with CID 1. In contrast, the WR
group showed no change in insulin secretion at CID 2 compared
with CID 1.
FIGURE 1. BMI evolution over the course of the intervention period.
Each dotted line depicts the weight curve of an individual; red and blue lines
represent WMs and WRs, respectively. The solid red and blue lines depict
the group average for WMs and WRs, respectively. Both WMs and WRs
experienced significant reductions in BMI during the 8-wk caloric
restriction. A group · time interaction analysis showed that the decreases
in BMI during the LCD were similar between the 2 groups. CID1 refers to
the time point before caloric restriction; CID2 refers to the time point after 8
wk of caloric restriction; CID3 refers to the time point after the 6-mo weight-
maintenance phase. CID, clinical investigation day; LCD, low-calorie diet;
WMs, weight maintainers; WRs, weight regainers.
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Gene expression analysis
Gene expression differences between WMs and WRs before and
after the LCD
Adipose tissue gene expression in WMs and WRs was first
examined at CID 1 and CID 2 independently. Although there
were no significant differences in bioclinical variables at CID 1
between WM and WR subjects, a gene expression analysis
showed that 1292 genes were differentially expressed between
the 2 groups before commencing the LCD. Despite this large
number of differentially expressed genes, a functional pathway
analysis failed to detect any differences in KEGG biological
pathways between the 2 groups. At CID 2, the 2 groups of
subjects appeared to be more similar with regard to their
scAT gene expression profiles, with only 77 genes identified as
differentially expressed between WMs and WRs. Again, no
KEGG pathways were found to differ significantly between the
groups.
Effects of LCD-induced weight loss on gene expression in WMs
and WRs
The primary goal of the current study was to assess the dif-
ferences in LCD-induced changes in gene expression in subjects
classified as WMs and WRs. When comparing changes in gene
expression between CID 1 and CID 2, 1291 and 1298 genes were
differentially expressed in WMs and WRs, respectively. More
specifically, 583 genes were upregulated and 708 were down-
regulated in the WMs, whereas 628 genes were upregulated and
670 were downregulated in the WRs. The most significant
downregulated gene in both WM and WR was stearoyl-CoA
desaturase (SCD1; WMs: 23.4-fold; WRs: 22.5-fold), the rate-
limiting enzyme responsible for the conversion of SFAs into
MUFAs (30). Expression changes for SCD1 were confirmed by
real-time RT-PCR (WMs: 21.8-fold; WRs: 22.0-fold; P ,
0.05). In WMs, the most upregulated gene was cell death–in-
ducing DFFA-like effector a (CIDEA; +2.2-fold), which was not
differentially regulated in WRs. This gene plays an important
role in adipose tissue energy expenditure and lipid accumula-
tion, in particular in increasing fat oxidation (31). We confirmed
the increase in CIDEA expression during the LCD in WMs by
real-time RT-PCR (+1.9-fold; P , 0.05). In WRs, the most
upregulated gene was vimentin (VIM; +2.0-fold). This gene,
expressed in fibroblasts and preadipocytes, was unique to WRs
and is thought to play an important role in the cellular remod-
eling that occurs during adipocyte differentiation (32). We were
unable to confirm a significant increase in VIM expression in
WRs with real-time RT-PCR (+1.2-fold, P = 0.17).
The 2 gene lists for WMs and WRs were further dissected to
better explore the shared and unique gene expression responses to
the LCD between the 2 groups. A total of 1027 and 1034 genes
were uniquely regulated in WMs and WRs, respectively (Figure
2). Although there were a large number of differentially ex-
pressed genes unique to the 2 groups, the functional analysis
showed that these genes tended to belong to similar functional
pathways (Figure 2). The LCD caused an increase in ribosomal
genes and decreases in oxidative phosphorylation and metabo-
lism pathways in both groups. The genes associated with oxi-
dative phosphorylation are also found in other pathways, which
is why pathways related to Alzheimer, Huntington, and Par-
kinson disease appear in Figure 2; however, it is the oxidative
phosphorylation pathway that is most relevant when considering
adipose tissue gene expression. The LCD caused a decrease in
the valine, isoleucine, and leucine degradation pathway (related
to 10 genes: ABAT, ACAA2, ALDH6A1, AOX1, BCKDHB, DLD,
HIBADH, HMGCS1, HSD17B10, and MCCC1) in WM subjects,
whereas the LCD caused a decrease in the fructose and mannose
metabolism pathway (related to 6 genes: ALDOA, ALDOB,
KHK, MPI, PFKM, and PFKP) in WR subjects.
After removing genes uniquely regulated in the 2 groups, 264
genes were differentially expressed in both WMs and WRs;
however, directional concordance was not always maintained. As
depicted in Figure 2, 170 genes were in directional concordance,
meaning that the LCD had a similar effect on gene expression in
both WM and WR groups. In contrast, 94 genes were regulated
oppositely, meaning that the LCD had a different effect on gene
expression in each group.
TABLE 1
LCD response in each group, as shown in commonly measured bioclinical variables1
Bioclinical variable
WMs (n = 20) WRs (n = 20) P value
CID 1 CID 2 CID 1 CID 2 Main effect, time Interaction, group · time2
Weight (kg) 91.8 6 2.7 82.1 6 2.6 91.9 6 2.8 83.2 6 2.6 ,0.0001 0.1568
BMI (kg/m2) 33.5 6 0.9 29.9 6 0.8 33.5 6 0.9 30.3 6 0.9 ,0.0001 0.1053
Fasting cholesterol (mmol/L) 5.1 6 0.2 4.2 6 0.2 4.9 6 0.2 4.1 6 0.2 ,0.0001 0.5989
Fasting triglycerides (mmol/L) 1.3 6 0.1 1.0 6 0.1 1.1 6 0.1 1.0 6 0.1 0.0024 0.0627
Fasting HDL (mmol/L) 1.2 6 0.1 1.1 6 0.1 1.3 6 0.1 1.1 6 0.1 0.0055 0.1552
Fasting fructosamine (lmol/L) 206 6 5 207 6 4 202 6 4 200 6 5 0.8120 0.6489
Fasting adiponectin (lg/mL) 9.2 6 1.0 10.4 6 1.0 9.8 6 1.0 10.4 6 1.0 0.1072 0.5832
Fasting CRP (mg/L) 4.6 6 0.8 3.4 6 0.9 4.1 6 0.6 4.8 6 1.3 0.7991 0.1238
Fasting glucose (mmol/L) 5.0 6 0.1 4.7 6 0.1 5.0 6 0.1 4.7 6 0.1 ,0.0001 0.7126
Fasting insulin (lIU/mL) 10.9 6 1.1 6.2 6 0.9 8.9 6 0.8 6.2 6 0.8 ,0.0001 0.0479
HOMA-IR 2.8 6 0.4 2.2 6 0.5 2.3 6 0.4 1.6 6 0.4 0.1326 0.8705
1 All values are means 6 SEMs. The table includes bioclinical variables at CID 1 and CID 2 in 20 women classified as WMs and in 20 women classified
as WRs. A mixed-model ANOVA was generated by using groups, times, and the interaction between group and time (group · time) as fixed effects and the
subject ID as a random effect (to account for repeated measurements). There was no group effect at either CID 1 or CID 2, reinforcing that groups were well
matched. CID 1 refers to the time point before caloric restriction; CID 2 refers to the time point after 8 wk of caloric restriction. CID, clinical investigation
day; CRP, C-reactive protein; LCD, low-calorie diet; WMs, weight maintainers; WRs, weight regainers.
2 A significant interaction was observed for fasting insulin, and a borderline interaction was observed for fasting triglycerides.
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Those genes in directional concordance suggest that the LCD
caused a decrease in the biosynthesis of unsaturated fatty acids
and a-linoleic metabolism pathways in both WMs and WRs.
These pathways include such genes as fatty acid desaturase 1
(FADS1), fatty acid desaturase 2 (FADS2), acyl-CoA oxidase 1
(ACOX), and stearoyl-CoA desaturase (SCD1). Changes in
FADS1 expression were confirmed by real-time RT-PCR (WMs:
21.9-fold; WRs: 21.8-fold; P , 0.05). In addition, a subset of
genes related to ribosomal pathways was upregulated by the
LCD in WMs and WRs.
We also examined pathways that were oppositely regulated by
the LCD (“OPP” in Figure 2) in the WM andWR groups. Several
genes related to focal adhesion functions were upregulated in
WRs and downregulated in WMs after the LCD: catenin b1
(CTNNB1), fibronectin 1 (FN1), mitogen-activated protein ki-
nase 1 (MAPK1), PTK2 protein tyrosine kinase 2 (PTK2),
b-actin (ACTB), and caveolin 1 (CAV1). These genes play im-
portant roles in the coordination of the extracellular matrix and
mediate processes such as cell growth and differentiation and
intracellular signaling, suggesting that an LCD had different
effects on extracellular matrix remodeling in the 2 groups. In-
terestingly, the LCD resulted in the increased expression of
genes related to apoptosis and the p53 signaling pathway in WM
subjects and not in WR subjects. More specifically, caspase 3
(CASP3) and caspase 8 (CASP8) were upregulated in WMs,
whereas these genes were downregulated in WRs. The upregu-
lation of CASP8 gene expression in WMs was validated by real-
time RT-PCR (+1.7 fold; P , 0.05), as was the downregulation
in WR subjects (21.2 fold; P , 0.05). Both CASP3 and CASP8
play crucial roles in initiating programmed cell death, suggesting
that greater cell death in scAT during an LCD may underlie
successful short-term weight maintenance.
Reporter metabolite analysis
To assess how the transcriptional differences inWMs andWRs
most likely affected downstream metabolism, we overlaid our
FIGURE 2. Venn diagram showing the overlap in differentially expressed genes after the LCD in WMs and WRs. Functional analyses showed that although
the genes regulated by the LCD in WMs and WRs differ, they are related to similar functional processes. The LCD caused a significant decrease in the valine,
leucine, and isoleucine degradation pathway in WM subjects. The LCD caused a significant decrease in the fructose and mannose metabolism pathway in WR
subjects. Genes that are differentially expressed by the LCD in both WMs and WRs were not always directionally concordant. Oxidative phosphorylation and
biosynthesis of unsaturated fatty acid pathways decreased with the LCD in both WMs and WRs. The apoptosis pathway was upregulated by the LCD in WMs
compared with WRs. [ and Y indicate an increase and decrease, respectively, during the LCD. DC, genes in directional concordance (ie, up or down in WM
and WR subjects); LCD, low-calorie diet; OPP, genes that are not directionally concordant (ie, up in WM and down in WR subjects or vice versa); WM,
weight maintainer; WR, weight regainer.
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gene expression data with the EHMN reconstruction (28) and
used the reporter metabolite analysis (26) to identify metabolites
that may represent biomarkers for successful weight mainte-
nance. It is apparent by the network structure that the LCD
induces a more highly coordinated response in WM subjects than
in WR subjects, as represented by the dense and highly inter-
connected network (Figure 3, A and B); however, there are
some shared and distinct features within these 2 networks that
are noteworthy.
Metabolites identified as significantly downregulated by the
LCD in both WMs andWRs were (2R,4S)-2,4-diaminopentanoate
and 2-amino-4-oxopentanoic acid from the D-arginine and D-
ornithine pathway (P = 4.5 · 1024 and P = 2.0 · 1026, re-
spectively). Their significance was driven by the GAPDH gene,
which was downregulated in both groups during caloric restriction
(WMs: 21.16-fold; WRs: 21.17-fold).
Interestingly, we observed a global pattern in the metabolite
network that was unique to WMs and related to a large number of
differentially expressed enzymes. The LCD resulted in a marked
coordinated downregulation in enzymes associated with fatty
acid metabolism, citric acid cycle, and oxidative phosphorylation
in WM subjects, a signature that was absent in WRs. More
specifically, several metabolites displayed differential expression
in their associated enzymes: NADPH, NADP+, NADH, H+, CoA,
acetyl-CoA, acyl-CoA, stearoyl-CoA, oleoyl-CoA, palmitoyl-
CoA, and palmitoleoyl-CoA (Table 2). The majority of these
metabolites (9 out of 11) were previously identified in the Capel
et al (20) study, in which the authors also reported a marked
downregulation in the same enzymes during energy restriction.
Most of these metabolites were related to a large number of
enzymes (shown by the numerous connections to several enzymes
in the metabolic network), which reinforced the differences in
network connectivity observed between WMs and WRs, as these
metabolites were not significantly regulated in the WR group.
DISCUSSION
Considerable interindividual variability in weight maintenance
after caloric restriction has been observed. The present study was
designed to assess whether changes in scAT gene expression
profiles during the weight-loss phase of a dietary intervention
protocol could be used to predict changes in body weight during
a subsequent 6-mo weight-maintenance phase. A unique aspect
of this work lies with the fact that the subjects used for the current
study were selected out of the larger DiOGenes cohort to ensure
that there were no differences in the bioclinical values used as
selection criteria (Table 1). This analysis showed that an 8-wk
LCD triggered distinct changes in scAT gene expression in
subjects classified as WMs (0–10% weight regain) compared
with WRs (50–100% weight regain). Furthermore, only the WM
group experienced changes in plasma triglyceride concentrations
and insulin secretion during the LCD.
Fasting triglyceride concentrations decreased significantly
with the LCD in theWMgroup only. Schwab et al (33) previously
reported decreases in triglycerides enriched in saturated and
short-chain fatty acids after energy restriction, which were as-
sociated with improved insulin sensitivity. A larger follow-up
study failed to find significant decreases in plasma triglycerides
(15), suggesting variability in response to an energy-restricted
diet. Weight maintenance was not assessed in either study;
therefore, it is unclear whether a relation exists between the
changes in triglycerides and successful 6-mo weight maintenance.
Both groups of subjects experienced significant decreases in
fasting insulin concentrations at CID 2 compared with CID 1.
Although the decrease in fasting insulin appeared to be greater in
the WM group than in the WR group, it is important to note
that both groups experienced the expected decreases in fasting
insulin concentrations associated with LCD-induced weight loss.
Therefore, our data do not suggest that fasting insulin is a reliable
predictor of weight maintenance. This agrees with a previous
study by Crujeiras et al (34), in which baseline fasting plasma
insulin concentrations were reported to not predict weight regain.
A significant reduction in insulin secretion after the LCD was
observed in theWM but not in theWR group (see Supplementary
Figure 2 under “Supplemental data” in the online issue). This is
an intriguing finding that suggests that studying insulin secretion
in response to a glucose challenge at various stages during
a weight-loss and weight-maintenance intervention study may
prove interesting. In the current study, we used fasting insulin
concentrations at CID 1 to match our WM and WR groups;
however, it is important to note that data regarding insulin secretion
in response to an OGTT are not routinely used for bioclinical
matching of different subject groups. When we subsequently
examined insulin secretion data at CID 1, we found that the WM
group had significantly higher insulin secretion than did the WR
group. Moreover, weight loss induced by the LCD led to sig-
nificant reductions in insulin secretion in the WM group only. It
is therefore tempting to suggest that an individual’s capacity to
improve insulin sensitivity after weight loss is a possible pre-
dictor of successful weight maintenance. However, as shown in
Supplementary Figure 2, significant variability in the change in
insulin secretion after the LCD was observed between in-
dividuals, thereby reinforcing the inherent challenge associated
with identifying predictors and the absolute necessity for their
independent validation. A number of studies have attempted to
determine whether insulin secretion plays a role in long-term
FIGURE 3. Metabolic reconstruction network analysis corresponding to LCD-induced changes in gene expression in WMs (A) and WRs (B). We used
a high-confidence metabolic network reconstruction to search for metabolites that are catalyzed by enzymes that exhibit coordinated changes in gene
expression levels during the LCD. The metabolic networks consist of metabolites (circles) that are connected to enzymes (diamonds) that catalyze the
metabolites. Only metabolites linked to enzymes for which the underlying genes are differentially expressed during the LCD are shown. Metabolite circles are
scaled according to their significance (ie, larger circles reflect smaller P values), in which the P value denotes the significance of being a metabolic “hot spot.”
A metabolite that is connected to a large number of differentially regulated enzymes (between CID1 and CID2) will be depicted by a larger circle. The ranges
of P values, which correspond to circle size, are (A) 2.0 · 1025 to 0.05 and (B) 8.9 · 10210 to 0.05. For enzymes, red indicates upregulation and green
indicates downregulation in gene expression. The impact of the LCD on scAT gene expression is more highly coordinated in WMs than in WRs, as represented
by the dense and highly interconnected network. In WMs (A), the LCD elicits a marked coordinated downregulation of genes coding for enzymes associated
with fatty acid metabolism, citric acid cycle, and oxidative phosphorylation (shaded in yellow). That signature is absent in the WR analysis (B) in which
alternate sites in metabolism are active. Highly significant metabolites common to both WMs and WRs are shaded in purple. CID, clinical investigation day;
LCD, low-calorie diet; scAT, subcutaneous adipose tissue; WMs, weight maintainers; WRs, weight regainers.
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body-weight regulation (35, 36); however, previous research has
tended to examine whether insulin secretion affects weight gain.
Schwartz et al (35) showed that reduced insulin secretion was
a significant predictor for weight gain, and Chaput et al (37)
showed that 30-min insulin concentrations during an OGTT
were positively associated with 6-y weight gain. It is difficult to
directly compare the outcomes of our study and these other
studies because of different experimental designs; however, our
data suggest that changes in insulin secretion after weight loss
may be associated with changes in body weight.
The present study provides a novel contribution to the existing
literature by studying whether LCD-induced changes in scAT
gene expression can be used to predict successful short-term
weight maintenance. Functional analysis of gene expression data
showed that focal adhesion, apoptosis and p53 signaling path-
ways were differentially regulated during an LCD in WMs and
WRs. In the WM group, subjects experienced a decrease in the
focal adhesion pathway, which consists of extracellular matrix
genes associated with diverse functions such as inflammation and
cell growth and differentiation. Because the present study used
a discovery-based approach and the genes related to focal ad-
hesion have wide-ranging roles in various signaling pathways, it
is difficult to predict whether extracellular remodeling is higher
or lower in each group. Rather, we report here that an LCD has
different effects on the extracellular matrix in WM and WR
subjects.
The LCD caused an increase in caspase gene expression in
WM subjects (ie, apoptosis pathway), suggesting that these
subjects may be experiencing an increase in scAT apoptosis. In
addition, CIDEA, the most highly upregulated gene in WMs has
also been shown to regulate apoptosis in different cell types,
including in adipocytes (38). Little previous work has examined
the impact of diet-induced weight loss on adipose tissue apo-
ptosis. Aubin et al (39) studied obese subjects and found that an
inhibitor of cellular adipose apoptosis was higher in the stroma-
vascular fraction of scAT after weight loss. This work aligns
with that of Alkhouri et al (40) who recently showed that cas-
pase-3 was upregulated (ie, increased apoptosis) in diet-induced
obese mice. Our results suggest the opposite: an LCD increased
CASP3 and CASP8 expression only in individuals experiencing
successful short-term weight maintenance. Although our study
and that of Alkhouri et al appear to conflict, there are several
noteworthy differences. Firsy, different fat depots were used in
these studies, suggesting that omental and subcutaneous fat de-
pots may regulate apoptosis pathways differently after changes
in body weight. Second, Alkhouri et al compared morbidly
obese and lean individuals, whereas we recruited only moder-
ately obese participants. Despite these differences, both studies
show that changes in body weight may influence adipose tissue
apoptosis. Because of the variable response observed between
individuals after caloric restriction, it appears likely that strati-
fying our population into WM and WR groups better highlighted
subtle differences in scAT apoptosis. The notion that greater
scAT apoptosis during an LCD may predispose individuals to
successful weight maintenance is intriguing; however, future
studies are required to confirm this finding, to identify the spe-
cific adipose tissue cell type in which the apoptosis pathway is
increased, and to determine the physiologic outcome for this
increase.
Interestingly, the metabolic network analysis was able to pick
up several metabolites related to fatty acid metabolism, the citric
acid cycle, and oxidative phosphorylation that were specifically
regulated by the LCD inWMs and associated with a large number
of downregulated enzymes. It is most likely that this analysis was
able to detect these differences because it incorporates metabolic
network topology, a feature that is often lacking in classical
bioinformatic functional analyses such as FunNet. The marked
differential expression and the major downregulation in enzymes
TABLE 2
Reporter metabolites identified in WMs and WRs and their agreement with an independent study1
WMs WRs Capel et al (20)
Reporter metabolite P value2 [ Reactions Y Reactions P value2 [ Reactions Y Reactions P value2 [ Reactions Y Reactions
NADPH 0.008 57 88 0.217 75 70 0.026 6 16
Oleoyl-CoA 0.009 4 4 0.111 2 6 0.020 0 2
CoA 0.009 42 67 0.427 45 64 0.002 6 15
Acetyl-CoA 0.012 24 46 0.768 26 44 0.035 2 10
Stearoyl-CoA 0.013 5 8 0.164 3 10 0.020 0 2
NADP+ 0.019 58 90 0.237 76 72 0.020 6 16
H+ 0.031 128 204 0.117 149 183 0.037 9 38
NADH 0.033 50 74 0.217 75 70 0.085 3 21
Palmitoyl-CoA 0.039 10 17 0.105 7 20 0.054 1 2
Acyl-CoA 0.044 18 18 0.202 13 23 ,0.001 0 6
Palmitoleoyl-CoA 0.050 7 8 0.154 6 9 0.005 0 2
1 To assess how the transcriptional differences in WMs and WRs most likely affected downstream metabolism, we overlaid our gene expression data with
the EHMN reconstruction and used the reporter metabolite algorithm to identify metabolites that vary between the 2 groups. We compared our results with
those of Capel et al (20). Note that even though EHMN reconstruction was used in both studies, the number of enzymes detected in each network differed
because of the different algorithms used to identify differentially regulated genes. [ and Y, the number of metabolic reactions in which the metabolite is
catalyzed by an enzyme that is either up- or downregulated during the low-calorie diet; EHMN, Edinburgh human metabolic network; WMs, weight
maintainers; WRs, weight regainers.
2 The unadjusted P values of reporter metabolites denote their significance of being metabolic “hot spots.” In other words, these metabolites are
connected to more differentially regulated enzymes (between clinical investigation days 1 and 2) than is expected by chance. P , 0.05 for significant
changes in reporter metabolites.
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catalyzing fatty acid metabolism, the citric acid cycle, and ox-
idative phosphorylation observed during the LCD in WMs
suggest that individuals predisposed to successful weight
maintenance may be able to decrease fat accumulation by co-
ordinating a better overall metabolic response.
Some limitations of the current study are worth noting. We
classified subjects as WMs or WRs based solely on changes in
body weight during the weight-loss and weight-maintenance
phases, as previously reported (11, 41); however, we acknowl-
edge that the regulation of body weight is multifactorial and can
be influenced by environmental (eg, diet), lifestyle/behavioral
(eg, physical activity, psychological), and molecular (eg, gene
polymorphisms, gene expression) factors. The goal of the current
study was to assess the molecular contribution to 6-mo weight
maintenance; however, differences in energy intake and physical
activity may have also contributed to weight regain. We used 3-d
dietary records and pedometers to estimate energy intake and
physical activity; however, there are caveats to consider. The first
is that food records are widely recognized to have limitations,
such as underreporting food intake and portion size (42, 43), in
particular in the obese. Although we did not identify a significant
difference in energy intake between WMs and WRs at CID 3, the
WM group consumed ~500KJ/d less than did the WR group. We
cannot exclude that an additional 500 KJ/d over the course of 6
mo could contribute to differences in weight gain. Our data
regarding physical activity were incomplete; therefore we were
unable to account for the effect of physical activity on weight
maintenance/regain. Despite these limitations, our data suggest
that individuals who experience a highly coordinated tran-
scriptomic response to an LCD may provide new insight in
understanding the genetic/genomic contribution to successful
weight maintenance.
In conclusion, the current study shows that LCD-induced
changes in bioclinical variables and scAT gene expression may
foreshadow successful weight maintenance. The relation between
changes in insulin secretion and weight maintenance is in-
triguing, yet requires validation in other populations that vary in
sex and ethnicity before it can be considered a valid predictor for
successful weight maintenance. Furthermore, our study rein-
forces the continued need to explore the relevance of genetic and
metabolic factors in predicting changes in body weight and paves
theway to further explore towhat extent LCD-induced changes in
gene expression can be used to confidently predict short-term
weight maintenance.
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